Answers are grounded in this paper and cite their sources.
A main challenge for anticancer drugs is that the drugs can not arrive the cancer tissue at right time. In this work, a magnetic targeting nanoparticle based on hollow Fe3O4/graphene oxide (Fe3O4/GO) was developed as a potential tumor targeting drug carriers. The morphology results showed the Fe3O4 nanoparticles were uniformly wrapped by graphene oxide. After coating with graphene oxide, the Fe3O4/GO showed a higher saturation magnetization of 71.47 emu g−1 as compared to neat Fe3O4 nanoparticles. The drug loading and releasing experiment indicated the obtained Fe3O4/GO has a good loading capacity of of 0.41 mg mg−1 for 5-fluorouracil (5-FU) and a positive sensitive of acidic atmosphere. The CCK-8 assays of CMEC viability demonstrated the hollow Fe3O4/GO nanocarriers do not statistically exhibit toxicity with the concentration increasing from 2.5 to 40 μg mL−1 in vitro. These results suggested the prepared Fe3O4/GO has a potential application in anticancer drugs nanocarriers.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: